Rothera Mark Insider Trades

Insider Trading History

Track insider trading activity for Rothera Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Viracta Therapeutics
Viracta Therapeutics VIRX
President And CEO
Holding Value $4.66k 475,000 shares
Last Trade
Mar 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$470k 475,000 shares
$0.99
$0.01
Viracta Therapeutics
Viracta Therapeutics VIRX
President And CEO
Holding Value $980 100,000 shares
Last Trade
Dec 01, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.5k 47,906 shares
$0.49
$0.01
Viracta Therapeutics
Viracta Therapeutics VIRX
President And CEO
Holding Value $511 52,094 shares
Last Trade
Nov 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.5k 52,094 shares
$0.49
$0.01
Viracta Therapeutics
Viracta Therapeutics VIRX
President And CEO
Holding Value $3.92k 400,000 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 400,000 shares
$1.65
$0.01
Viracta Therapeutics
Viracta Therapeutics VIRX
President And CEO
Holding Value $13.5k 1,375,000 shares
Last Trade
Sep 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.16M 1,375,000 shares
$5.21
$0.01
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
See Remarks
Holding Value $1.57M 93,796 shares
Last Trade
Jan 01, 2020 Sale
$174M 1,261,975 shares
$137.50
$16.70
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $503k 6,125 shares
Last Trade
May 24, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.2k 2,000 shares
$12.58
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $2.77M 33,739 shares
Last Trade
May 24, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.2k 2,000 shares
$12.58
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $5.69M 69,227 shares
Last Trade
Mar 15, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$32.2k 2,966 shares
$10.85
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $2.61M 31,739 shares
Last Trade
Mar 15, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$32.2k 2,966 shares
$10.85
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $2.36M 28,773 shares
Last Trade
Feb 16, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.1k 3,125 shares
$13.78
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $5.93M 72,193 shares
Last Trade
Feb 16, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.1k 3,125 shares
$13.78
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $6.19M 75,318 shares
Last Trade
Jan 17, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$46k 3,125 shares
$14.71
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $2.11M 25,648 shares
Last Trade
Jan 17, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$46k 3,125 shares
$14.71
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $4.6M 56,000 shares
Last Trade
Jan 03, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$737k 65,600 shares
$11.23
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $921k 11,216 shares
Last Trade
Nov 14, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.1k 1,941 shares
$10.85
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $6.44M 78,443 shares
Last Trade
Nov 14, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.1k 1,941 shares
$10.85
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $762k 9,275 shares
Last Trade
Oct 10, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.5k 1,950 shares
$13.59
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $6.6M 80,384 shares
Last Trade
Oct 10, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.5k 1,950 shares
$13.59
$82.13
PTC Therapeutics
PTC Therapeutics PTCT
Chief Commercial Officer
Holding Value $602k 7,325 shares
Last Trade
Sep 26, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.9k 2,200 shares
$10.85
$82.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up